The global Anti-Camelid VHH Antibody market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Western Blot segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Anti-Camelid VHH Antibody include Genscript Biotech Corporation, Rockland Immunochemicals, Inc., ABclonal, Eurogentec, Jackson ImmunoResearch, Southern Biotech, LSBio, Stratech, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Anti-Camelid VHH Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Anti-Camelid VHH Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Camelid VHH Antibody. This report contains market size and forecasts of Anti-Camelid VHH Antibody in global, including the following market information:
Global Anti-Camelid VHH Antibody market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Anti-Camelid VHH Antibody companies in 2024 (%)
Total Market by Segment:
Global Anti-Camelid VHH Antibody market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Anti-Camelid VHH Antibody market segment percentages, by Type, 2024 (%)
Western Blot
ELISA
Global Anti-Camelid VHH Antibody market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Anti-Camelid VHH Antibody market segment percentages, by Application, 2024 (%)
Cell and Gene Therapy
Genetic Diagnosis
Others
Global Anti-Camelid VHH Antibody market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Anti-Camelid VHH Antibody market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Camelid VHH Antibody revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Anti-Camelid VHH Antibody revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genscript Biotech Corporation
Rockland Immunochemicals, Inc.
ABclonal
Eurogentec
Jackson ImmunoResearch
Southern Biotech
LSBio
Stratech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Camelid VHH Antibody, market overview.
Chapter 2: Global Anti-Camelid VHH Antibody market size in revenue.
Chapter 3: Detailed analysis of Anti-Camelid VHH Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Camelid VHH Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Camelid VHH Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Anti-Camelid VHH Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Camelid VHH Antibody Overall Market Size
2.1 Global Anti-Camelid VHH Antibody Market Size: 2024 VS 2032
2.2 Global Anti-Camelid VHH Antibody Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Camelid VHH Antibody Players in Global Market
3.2 Top Global Anti-Camelid VHH Antibody Companies Ranked by Revenue
3.3 Global Anti-Camelid VHH Antibody Revenue by Companies
3.4 Top 3 and Top 5 Anti-Camelid VHH Antibody Companies in Global Market, by Revenue in 2024
3.5 Global Companies Anti-Camelid VHH Antibody Product Type
3.6 Tier 1, Tier 2, and Tier 3 Anti-Camelid VHH Antibody Players in Global Market
3.6.1 List of Global Tier 1 Anti-Camelid VHH Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Camelid VHH Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Anti-Camelid VHH Antibody Market Size Markets, 2024 & 2032
4.1.2 Western Blot
4.1.3 ELISA
4.2 Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue & Forecasts
4.2.1 Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Anti-Camelid VHH Antibody Market Size, 2024 & 2032
5.1.2 Cell and Gene Therapy
5.1.3 Genetic Diagnosis
5.1.4 Others
5.2 Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue & Forecasts
5.2.1 Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Anti-Camelid VHH Antibody Market Size, 2024 & 2032
6.2 By Region - Global Anti-Camelid VHH Antibody Revenue & Forecasts
6.2.1 By Region - Global Anti-Camelid VHH Antibody Revenue, 2020-2025
6.2.2 By Region - Global Anti-Camelid VHH Antibody Revenue, 2026-2032
6.2.3 By Region - Global Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Anti-Camelid VHH Antibody Revenue, 2020-2032
6.3.2 United States Anti-Camelid VHH Antibody Market Size, 2020-2032
6.3.3 Canada Anti-Camelid VHH Antibody Market Size, 2020-2032
6.3.4 Mexico Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Anti-Camelid VHH Antibody Revenue, 2020-2032
6.4.2 Germany Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4.3 France Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4.4 U.K. Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4.5 Italy Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4.6 Russia Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4.7 Nordic Countries Anti-Camelid VHH Antibody Market Size, 2020-2032
6.4.8 Benelux Anti-Camelid VHH Antibody Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Anti-Camelid VHH Antibody Revenue, 2020-2032
6.5.2 China Anti-Camelid VHH Antibody Market Size, 2020-2032
6.5.3 Japan Anti-Camelid VHH Antibody Market Size, 2020-2032
6.5.4 South Korea Anti-Camelid VHH Antibody Market Size, 2020-2032
6.5.5 Southeast Asia Anti-Camelid VHH Antibody Market Size, 2020-2032
6.5.6 India Anti-Camelid VHH Antibody Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Anti-Camelid VHH Antibody Revenue, 2020-2032
6.6.2 Brazil Anti-Camelid VHH Antibody Market Size, 2020-2032
6.6.3 Argentina Anti-Camelid VHH Antibody Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue, 2020-2032
6.7.2 Turkey Anti-Camelid VHH Antibody Market Size, 2020-2032
6.7.3 Israel Anti-Camelid VHH Antibody Market Size, 2020-2032
6.7.4 Saudi Arabia Anti-Camelid VHH Antibody Market Size, 2020-2032
6.7.5 UAE Anti-Camelid VHH Antibody Market Size, 2020-2032
7 Companies Profiles
7.1 Genscript Biotech Corporation
7.1.1 Genscript Biotech Corporation Corporate Summary
7.1.2 Genscript Biotech Corporation Business Overview
7.1.3 Genscript Biotech Corporation Anti-Camelid VHH Antibody Major Product Offerings
7.1.4 Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.1.5 Genscript Biotech Corporation Key News & Latest Developments
7.2 Rockland Immunochemicals, Inc.
7.2.1 Rockland Immunochemicals, Inc. Corporate Summary
7.2.2 Rockland Immunochemicals, Inc. Business Overview
7.2.3 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Major Product Offerings
7.2.4 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.2.5 Rockland Immunochemicals, Inc. Key News & Latest Developments
7.3 ABclonal
7.3.1 ABclonal Corporate Summary
7.3.2 ABclonal Business Overview
7.3.3 ABclonal Anti-Camelid VHH Antibody Major Product Offerings
7.3.4 ABclonal Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.3.5 ABclonal Key News & Latest Developments
7.4 Eurogentec
7.4.1 Eurogentec Corporate Summary
7.4.2 Eurogentec Business Overview
7.4.3 Eurogentec Anti-Camelid VHH Antibody Major Product Offerings
7.4.4 Eurogentec Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.4.5 Eurogentec Key News & Latest Developments
7.5 Jackson ImmunoResearch
7.5.1 Jackson ImmunoResearch Corporate Summary
7.5.2 Jackson ImmunoResearch Business Overview
7.5.3 Jackson ImmunoResearch Anti-Camelid VHH Antibody Major Product Offerings
7.5.4 Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.5.5 Jackson ImmunoResearch Key News & Latest Developments
7.6 Southern Biotech
7.6.1 Southern Biotech Corporate Summary
7.6.2 Southern Biotech Business Overview
7.6.3 Southern Biotech Anti-Camelid VHH Antibody Major Product Offerings
7.6.4 Southern Biotech Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.6.5 Southern Biotech Key News & Latest Developments
7.7 LSBio
7.7.1 LSBio Corporate Summary
7.7.2 LSBio Business Overview
7.7.3 LSBio Anti-Camelid VHH Antibody Major Product Offerings
7.7.4 LSBio Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.7.5 LSBio Key News & Latest Developments
7.8 Stratech
7.8.1 Stratech Corporate Summary
7.8.2 Stratech Business Overview
7.8.3 Stratech Anti-Camelid VHH Antibody Major Product Offerings
7.8.4 Stratech Anti-Camelid VHH Antibody Revenue in Global Market (2020-2025)
7.8.5 Stratech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-Camelid VHH Antibody Market Opportunities & Trends in Global Market
Table 2. Anti-Camelid VHH Antibody Market Drivers in Global Market
Table 3. Anti-Camelid VHH Antibody Market Restraints in Global Market
Table 4. Key Players of Anti-Camelid VHH Antibody in Global Market
Table 5. Top Anti-Camelid VHH Antibody Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Anti-Camelid VHH Antibody Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Anti-Camelid VHH Antibody Revenue Share by Companies, 2020-2025
Table 8. Global Companies Anti-Camelid VHH Antibody Product Type
Table 9. List of Global Tier 1 Anti-Camelid VHH Antibody Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Camelid VHH Antibody Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2026-2032
Table 30. Genscript Biotech Corporation Corporate Summary
Table 31. Genscript Biotech Corporation Anti-Camelid VHH Antibody Product Offerings
Table 32. Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 33. Genscript Biotech Corporation Key News & Latest Developments
Table 34. Rockland Immunochemicals, Inc. Corporate Summary
Table 35. Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Product Offerings
Table 36. Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 37. Rockland Immunochemicals, Inc. Key News & Latest Developments
Table 38. ABclonal Corporate Summary
Table 39. ABclonal Anti-Camelid VHH Antibody Product Offerings
Table 40. ABclonal Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 41. ABclonal Key News & Latest Developments
Table 42. Eurogentec Corporate Summary
Table 43. Eurogentec Anti-Camelid VHH Antibody Product Offerings
Table 44. Eurogentec Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 45. Eurogentec Key News & Latest Developments
Table 46. Jackson ImmunoResearch Corporate Summary
Table 47. Jackson ImmunoResearch Anti-Camelid VHH Antibody Product Offerings
Table 48. Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 49. Jackson ImmunoResearch Key News & Latest Developments
Table 50. Southern Biotech Corporate Summary
Table 51. Southern Biotech Anti-Camelid VHH Antibody Product Offerings
Table 52. Southern Biotech Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 53. Southern Biotech Key News & Latest Developments
Table 54. LSBio Corporate Summary
Table 55. LSBio Anti-Camelid VHH Antibody Product Offerings
Table 56. LSBio Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 57. LSBio Key News & Latest Developments
Table 58. Stratech Corporate Summary
Table 59. Stratech Anti-Camelid VHH Antibody Product Offerings
Table 60. Stratech Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2020-2025)
Table 61. Stratech Key News & Latest Developments
List of Figures
Figure 1. Anti-Camelid VHH Antibody Product Picture
Figure 2. Anti-Camelid VHH Antibody Segment by Type in 2024
Figure 3. Anti-Camelid VHH Antibody Segment by Application in 2024
Figure 4. Global Anti-Camelid VHH Antibody Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Anti-Camelid VHH Antibody Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Anti-Camelid VHH Antibody Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Camelid VHH Antibody Revenue in 2024
Figure 9. Segmentation by Type � Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 13. By Region - Global Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 14. By Country - North America Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 15. United States Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 19. Germany Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 20. France Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 27. China Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 31. India Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 33. Brazil Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue Market Share, 2020-2032
Figure 36. Turkey Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2020-2032
Figure 40. Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. ABclonal Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Eurogentec Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Southern Biotech Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. LSBio Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Stratech Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
